Stockscreener 앱 받기
0.8101
6.44%
-0.0558
시장 영업 전:
.82
0.0099
+1.22%
Senti Biosciences Inc 주식(SNTI)의 최신 뉴스
Senti Biosciences completes enrollment in Phase 1 clinical trial of Senti-202 - marketscreener.com
Senti Biosciences Completes Enrollment In Phase 1 Clinical Trial Of Senti-202 - TradingView
Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) - The Manila Times
Leukemia cell therapy SENTI-202 heads for FDA talks after early remissions - Stock Titan
Does Senti Biosciences Inc. have a sustainable dividendShare Buyback & Smart Allocation Stock Tips - mfd.ru
Retail Surge: Is FONR benefiting from interest rate changesIPO Watch & Weekly Sector Rotation Insights - baoquankhu1.vn
Gains Recap: Does Senti Biosciences Inc have a sustainable dividendMarket Trend Summary & AI Driven Price Forecasts - baoquankhu1.vn
Senti Biosciences Inc. (SNTI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Mood: Should I trade or invest in Senti Biosciences IncInsider Selling & AI Forecast Swing Trade Picks - baoquankhu1.vn
Growth Value: What are the analyst revisions for Senti Biosciences IncIs ICON stock a good investment in YEAR2025 Top Decliners & Accurate Technical Buy Alerts - baoquankhu1.vn
Aug Movers: Does Senti Biosciences Inc have a sustainable dividend2025 Winners & Losers & Verified Momentum Stock Alerts - baoquankhu1.vn
Senti Biosciences, Inc. (NASDAQ:SNTI) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026 - The Manila Times
Insider Buy: Is Senti Biosciences Inc stock good for income investorsJuly 2025 Update & Growth Oriented Trading Recommendations - baoquankhu1.vn
US Market Recap: Will EQT Corporation stock go up in YEARPortfolio Value Report & Real-Time Buy Signal Alerts - baoquankhu1.vn
Can Senti Biosciences Inc sustain its profitability2025 Year in Review & Verified Momentum Stock Ideas - baoquankhu1.vn
Market Rankings: Is Senti Biosciences Inc benefiting from innovation trendsJuly 2025 Outlook & Technical Entry and Exit Tips - baoquankhu1.vn
Block Trades: Is Senti Biosciences Inc benefiting from innovation trendsInflation Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company's Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation - marketscreener.com
Senti Biosciences, Inc. Highlights FDA RMAT Designation for SENTI-202 in Virtual Investor CEO Connect Segment - Quiver Quantitative
Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company’s Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation - The Manila Times
FDA RMAT status and early leukemia data put Senti Bio therapy in focus - Stock Titan
Published on: 2026-01-14 09:14:03 - Bộ Nội Vụ
Breakouts Watch: Should I hold or sell Senti Biosciences Inc stock in 2025 - Bộ Nội Vụ
Senti Biosciences, Inc. (NASDAQ:SNTI) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference - The Manila Times
Trading Action: Why Senti Biosciences Inc. stock is a value investor pickJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - ulpravda.ru
Quarterly Recap: Can Senti Biosciences Inc. stock beat market expectations this quarterPortfolio Value Summary & Smart Money Movement Tracker - ulpravda.ru
Will Senti Biosciences Inc. stock outperform value stocksRisk Management & AI Forecasted Stock Moves - Улправда
Why Senti Biosciences Inc. stock is a value investor pick2025 Sector Review & Free Daily Entry Point Trade Alerts - Улправда
Why Senti Biosciences Inc. stock remains on buy listsM&A Rumor & Growth Focused Investment Plans - Улправда
Why Senti Biosciences Inc. stock is rated strong buyMarket Sentiment Review & Entry Point Strategy Guides - Улправда
Stock Market Recap: Is Senti Biosciences Inc. stock a good choice for value investorsEarnings Summary Report & Fast Gaining Stock Strategy Reports - ulpravda.ru
Can Senti Biosciences Inc. stock beat market expectations this quarterTrade Analysis Report & Weekly Watchlist of Top Performers - Улправда
Promising Biotech Stocks To Keep An Eye OnDecember 9th - MarketBeat
Guidance Update: Is Senti Biosciences Inc stock a good choice for value investorsAnalyst Downgrade & Free Verified High Yield Trade Plans - moha.gov.vn
Senti Biosciences, Inc. (SNTI) Stock: Faces Decline Despite Groundbreaking FDA Designation - parameter.io
How sustainable is Senti Biosciences Inc. stock dividend payoutEarnings Miss & High Yield Equity Trading Tips - Улправда
Comparing Longeveron (NASDAQ:LGVN) & Senti Biosciences (NASDAQ:SNTI) - Defense World
Will Senti Biosciences Inc. stock deliver strong dividend growthChart Signals & Growth Focused Stock Pick Reports - ulpravda.ru
Is Senti Biosciences Inc. stock a good choice for value investors2025 Macro Impact & Weekly High Return Stock Forecasts - Bölüm Sonu Canavarı
Income Plays: How institutional buying supports Senti Biosciences Inc. stock2025 Earnings Impact & Real-Time Volume Analysis - Улправда
Why retail investors pile into Senti Biosciences Inc. stock2025 Sector Review & Real-Time Volume Triggers - DonanımHaber
Senti Biosciences Announces New Employment Inducement Grants - The Manila Times
Does Senti Biosciences Inc. stock trade at a discount to peersMarket Movement Recap & Safe Capital Growth Plans - Улправда
Senti Biosciences, Inc. (NASDAQ:SNTI) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Senti Biosciences Earnings Notes - Trefis
1.24%
0.19%
자본화:
|
볼륨(24시간):